F 0756
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Ensure a licensed pharmacist perform a monthly drug regimen review, including the medical chart,
following irregularity reporting guidelines in developed policies and procedures.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, record review, and interview, the facility failed to ensure any drug regimen irregularities
reported by the Pharmacist Consultant were acted upon, for 1 of 5 residents (Resident #10) reviewed for
medication regimens. The facility failed to 's Pharmacy Consultant recommended the facility include
anti-psychotic side-effect monitoring for Resident #10's Risperdal and Perphenazine medication orders on
06/18/25 and 07/23/25. This failure could place residents receiving medications at risk for adverse
consequences and could cause a decline in their physical, mental, and psychosocial condition. Findings
included: Record review of Resident #10's Quarterly MDS Assessment, dated 07/16/25, reflected the
resident was a [AGE] year-old male who was admitted to the facility on [DATE]. He had a BIMS score of 13
indicating no cognitive impairment. His active diagnoses included anxiety disorder (a group of mental health
conditions characterized by excessive fear, worry, and anxiety that interfere with daily life), depression (a
mood disorder that causes persistent feelings of sadness and loss of interest), and schizophrenia (a
serious mental health condition that affects how people think, feel, and behave). His MDS indicated he was
taking antipsychotic medications on a routine basis. Record review of Resident #10's physician's orders,
dated 08/13/25, reflected the following: -Perphenazine Oral Tablet 16 MG, Give 1 tablet by mouth at
bedtime for m/b impulsive behavior related to Unspecified Mood [Affective] Disorder with a start date of
03/19/25. -Risperdal Oral Tablet 2 MG, Give 1 tablet by mouth two times a day for m/b auditory hallucination
related to Unspecific Mood [Affective] Disorder with a start date of 03/19/25. Record review of Resident
#10's August 2025 MAR reflected he received both Perphenazine and Risperdal every day as ordered.
Record review of Resident #10's undated care plan reflected the following: Focus: Psychotropic
Medications: [Resident #10] has DX: Depression w/hx suicidal ideations, anxiety, mood disorder and
receives daily medication therapy and is at risk for clinical complications.Interventions/Tasks: Administer
medications as ordered. Monitor/document for side effects and effectiveness. Monitor/record/report to MDS
prn side effects and adverse reactions of psychoactive medications: unsteady gait, tardive dyskinesia, EPS
(shuffling gait, rigid muscles, shaking), frequent falls, refusal to eat, difficulty swallowing, dry mouth,
depression, suicidal ideations, social isolation, blurred vision, diarrhea, fatigue, insomnia, loss of appetite,
weight loss, muscle cramps, nausea, vomiting, behavior symptoms not usual to the person. Record review
of Resident #10's Pharmacy Recommendations Form, dated 06/18/25, reflected the following: Risperdal
and Perphenazine require anti-psychotic side effect monitoring. Record review of Resident #10's Pharmacy
Recommendations Form, dated 07/23/25, reflected the following: Risperdal and Perphenazine require
anti-psychotic side effect monitoring. Interview on 08/14/25 at 12:03 PM, with Resident #10 revealed he
had no concerns about his medications and did not think he had experienced any side effects from them.
Interview on 08/14/25 at 9:21 AM, LVN F revealed she was Resident #10's nurse and was very familiar with
him and
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 7
Event ID:
675977
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
675977
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
08/14/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Village Creek Nursing & Rehabilitation
3825 Village Creek Rd
Fort Worth, TX 76119
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0756
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
FORM CMS-2567 (02/99)
Previous Versions Obsolete
his care. She stated she knew Resident #10 had an order for and was administered Risperdal and
Perphenazine daily. She said she monitored the resident for side-effects of those medications daily. She
stated she thought Resident #10 had an order for side-effect monitoring. She stated normally when a
medication order was added to a resident's chart, which required side-effect monitoring, that order for
side-effect monitoring was also added. LVN F said she reviewed Resident #10's orders and did not see an
order for side-effect monitoring. Interview on 08/14/25 at 9:39 AM, the ADON revealed the facility had
standing orders when it came to side effect monitoring of any medications that required them, including
anti-psychotics such as Risperdal and Perphenazine. She stated anti-psychotic medications required
side-effect monitoring. She stated the nurse, who put the order into the resident's chart, should have also
added the side-effect monitoring order as well. The ADON said she was responsible for completing and
following-up on the pharmacy recommendations each month. She stated when she reviewed the pharmacy
recommendations for Resident #10, she thought she saw the order for the side-effect monitoring for the two
medications, so she checked them off. She stated she should have noticed the side-effect monitoring order
was not there, and she should have added it then. Interview on 08/14/25 at 10:17 AM, the DON revealed
normally the nurse, who added the new medication order, would also add the side-effect monitoring for it as
well if it were an anti-psychotic medication. She said she reviewed Resident #10's orders, and she saw the
side-effect monitoring order for his Risperdal and Perphenazine medications were missing. She said the
ADON also reviewed new orders for residents and could have caught that the order was missing and added
it. She stated the ADON was also responsible for following-up on the pharmacy recommendations each
month, and she would go behind her to review them to check and make sure they were completed. She
said she also thought that Resident #10's side-effect monitoring order was included in his orders already,
so she assumed it had been completed as well. She said the purpose of the pharmacy recommendations
were to see if a resident needed to be monitored or not. She stated if pharmacy recommendations were not
followed or completed, a resident could experience a potential side-effect of a medication. Record review of
the facility's current, undated Consultant Pharmacist Services Provider Requirements policy reflected: .5.
The consultant pharmacist provides consultation on all aspects of the provision of pharmacy services in the
facility. In collaboration with facility staff, the consultant pharmacist helps to identify, communicate, address,
and resolve concerns and issues related to the provision of pharmaceutical services .
Event ID:
Facility ID:
675977
If continuation sheet
Page 2 of 7
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
675977
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
08/14/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Village Creek Nursing & Rehabilitation
3825 Village Creek Rd
Fort Worth, TX 76119
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0757
Ensure each resident’s drug regimen must be free from unnecessary drugs.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, interview, and record review, the facility failed to ensure each resident's drug regimen was free
of unnecessary medication for 1 of 5 residents (Resident #10) reviewed for unnecessary medication. The
facility did not monitor Resident #10 for side-effects related to the use of the anti-psychotic medications
Risperdal and Perphenazine. This failure could place the residents at risk for adverse consequences of
medication. Findings included: Record review of Resident #10's Quarterly MDS Assessment, dated
07/16/25, reflected the resident was a [AGE] year-old male who was admitted to the facility on [DATE]. He
had a BIMS score of 13 indicating no cognitive impairment. His active diagnoses included anxiety disorder
(a group of mental health conditions characterized by excessive fear, worry, and anxiety that interfere with
daily life), depression (a mood disorder that causes persistent feelings of sadness and loss of interest), and
schizophrenia (a serious mental health condition that affects how people think, feel, and behave). His MDS
indicated he was taking antipsychotic medications on a routine basis. Record review of Resident #10's
physician's orders, dated 08/13/25, reflected the following: -Perphenazine Oral Tablet 16 MG, Give 1 tablet
by mouth at bedtime for m/b impulsive behavior related to Unspecified Mood [Affective] Disorder with a start
date of 03/19/25. -Risperdal Oral Tablet 2 MG, Give 1 tablet by mouth two times a day for m/b auditory
hallucination related to Unspecific Mood [Affective] Disorder with a start date of 03/19/25. Record review of
Resident #10's August 2025 MAR reflected he received both Perphenazine and Risperdal every day as
ordered. Record review of Resident #10's undated care plan reflected the following: Focus: Psychotropic
Medications: [Resident #10] has DX: Depression w/hx suicidal ideations, anxiety, mood disorder and
receives daily medication therapy and is at risk for clinical complications.Interventions/Tasks: Administer
medications as ordered. Monitor/document for side effects and effectiveness. Monitor/record/report to MDS
prn side effects and adverse reactions of psychoactive medications: unsteady gait, tardive dyskinesia, EPS
(shuffling gait, rigid muscles, shaking), frequent falls, refusal to eat, difficulty swallowing, dry mouth,
depression, suicidal ideations, social isolation, blurred vision, diarrhea, fatigue, insomnia, loss of appetite,
weight loss, muscle cramps, nausea, vomiting, behavior symptoms not usual to the person. Interview on
08/14/25 at 12:03 PM, with Resident #10 revealed he had no concerns about his medications and did not
think he had experienced any side-effects from them. Interview on 08/14/25 at 9:21 AM, LVN F revealed
she was Resident #10's nurse, and she was very familiar with him and his care. She stated she knew
Resident #10 had an order for and was administered Risperdal and Perphenazine daily. She stated she
monitored the resident for side-effects of those medications daily. She said she thought Resident #10 had
an order for side-effect monitoring. She stated normally when a medication order was added to a resident's
chart, which required side-effect monitoring, that order was also added. She said she reviewed Resident
#10's orders, and she did not see an order for side-effect monitoring. Interview on 08/14/25 at 9:39 AM, the
ADON revealed the facility had standing orders when it came to side-effect monitoring of any medications
that required them, including anti-psychotics such as Risperdal and Perphenazine. She stated
anti-psychotic required side-effect monitoring. She stated the nurse, who put the order into the resident's
chart, should have also added the side-effect monitoring order as well. She stated she went through
residents' new orders as well to check to make sure they were all correct. The ADON said if she had seen
that the side-effect monitoring order was missing, she would have added it to Resident #10's orders.
Interview on 08/14/25 at 10:17 AM, the DON revealed normally the nurse, who added the new medication
order, would also add the side-effect monitoring for it as well if it were an anti-psychotic medication. She
said she reviewed Resident #10's orders, and she
Residents Affected - Few
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
675977
If continuation sheet
Page 3 of 7
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
675977
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
08/14/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Village Creek Nursing & Rehabilitation
3825 Village Creek Rd
Fort Worth, TX 76119
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0757
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
FORM CMS-2567 (02/99)
Previous Versions Obsolete
saw the side-effect monitoring order for his Risperdal and Perphenazine medications were missing. She
stated the ADON also reviewed new orders for residents and could have caught that the order was missing
and added it. She stated the purpose of having an order to monitor for side-effects of a medication was to
ensure there were no side-effects affecting the resident from the medication. She said by taking the
medication, the resident could experience side-effects from taking an anti-psychotic; if those were not
monitored, the medication may need to be changed. She stated staff were trained to know to include the
side-effect monitoring orders with any medication that required it. Record review of the facility's current,
undated Psychotherapeutic Drug Management policy reflected: .X. Nursing Responsibility: H. The
medication will be written on the Medication Administration Record (MAR) with the following information: i.
Medication, dose, and time of administration. ii. Manifestations for the drug i.e. hitting others etc. iii. Side
effects of the drug i.e. drooling, dry mouth, abnormal gait etc.
Event ID:
Facility ID:
675977
If continuation sheet
Page 4 of 7
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
675977
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
08/14/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Village Creek Nursing & Rehabilitation
3825 Village Creek Rd
Fort Worth, TX 76119
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0761
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Ensure drugs and biologicals used in the facility are labeled in accordance with currently accepted
professional principles; and all drugs and biologicals must be stored in locked compartments, separately
locked, compartments for controlled drugs.
Based on observations, record reviews, and interviews the facility failed to ensure all drugs were stored in
locked compartments for 1 of 6 carts (Cart #3) reviewed for medication storage. The facility failed to ensure
Cart #3 was secured when not in use.This failure could place residents at risk of gaining access to
medications not prescribed to them, leading to allergic reactions or overdoses. Findings
included:Observation on 08/13/25 at 2:44 PM revealed Medication Cart #3 was stored at the nurse's
station. Observation of the lock revealed it was in the secured position, but a check of the drawers revealed
drawer #2 was able to be opened. The other drawers on the cart were locked and were not able to be
opened. RN A obtained the keys to the cart, unlocked the cart, and then re-locked the cart; however, drawer
#2 on the cart continued to be unlocked. Observation of the contents of drawer #2 revealed it contained the
prescription medication cards for the residents of the 200 Hall. The medications included blood pressure
medications, anti-viral medications, sleep medications, potassium pills, thyroid medications, diabetic
medications, cardiac medications, and anti-nausea medications. RN A moved the cart to the interior of the
nurses' station and called for maintenance to check the cart. Interview on 08/13/25 at 2:46 PM with RN A
revealed the medication cart should always be secured when staff were not physically present to prevent
residents from accessing the medications in the cart. She stated the risk to residents was a resident taking
a medication not prescribed for them and having unwanted side-effects. In an interview on 08/14/25 at
10:32 AM with the DON she stated her expectation was for the nurses and medication aides to lock their
carts when they were not standing at the cart passing medications. She stated the risk of a medication cart
not being secured was a resident gaining access to medications not prescribed for them and having a
reaction to the medication. She stated maintenance was unable to fix the drawer on Cart #3, so the cart
was exchanged for a different cart until the drawer could be fixed or replaced. Record review of the facility's
Storage of Medications policy, dated August 2020, reflected: Medications and biologicals are stored safely,
securely, and properly, following manufacturer's recommendations or those of the supplier. The medication
supply is accessible only to licensed nursing personnel, pharmacy personnel, or staff members lawfully
authorized to administer medications. 2.Medication rooms, carts, and medication supplies are locked when
they are not attended by persons with authorized access.
Event ID:
Facility ID:
675977
If continuation sheet
Page 5 of 7
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
675977
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
08/14/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Village Creek Nursing & Rehabilitation
3825 Village Creek Rd
Fort Worth, TX 76119
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0925
Make sure there is a pest control program to prevent/deal with mice, insects, or other pests.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, interview, and record review, the facility failed to maintain an effective pest control program so
that that the facility is free of pests and rodents in 1 of 6 resident rooms (Resident #73) reviewed for pest
control. The facility failed to ensure Resident #73's room was free of ants. This failure could place residents
at risk of having pests in their rooms and insect bites. Findings included: Record review of Resident #73's
Quarterly MDS Assessment, dated 07/26/25, reflected the resident was an [AGE] year-old female initially
admitted to the facility on [DATE]. The MDS reflected the resident had moderate cognitive impairment with a
BIMS score of 8. The MDS also reflected diagnoses of metabolic encephalopathy (condition where brain
dysfunction occurs due to issues with the body's metabolism), adult failure to thrive (a syndrome
characterized by weight loss, decreased appetite, poor nutrition, and inactivity, often accompanied by other
symptoms like dehydration, depression, impaired immune function, and cognitive decline), and coronary
artery disease (damage or disease in the heart's major blood vessels caused by the build-up of plaque).
Record review of Resident #73's care plan revised on 08/07/25 reflected the resident had an ADL self-care
performance deficit related to impaired cognition (decline in mental abilities that can affect memory,
attention, reasoning, and problem-solving), encephalopathy, acute kidney failure (the kidneys inability to
filter waste products from the blood), hypertension (high blood pressure), muscle weakness, and
malnutrition (lack of proper nutrition). Interventions included the resident would require assistance with
ADLs (essential tasks necessary for maintaining personal health and hygiene). Record review of Resident
#5's Quarterly MDS Assessment, dated 07/22/25, reflected the resident was a [AGE] year-old female
initially admitted to the facility on [DATE]. The MDS reflected the resident's cognition was intact with a BIMS
score of 15. The MDS also reflected diagnoses of schizophrenia (a disorder that affects a person's ability to
think, feel, and behave clearly), depression (a mood disorder that causes persistent feelings of sadness
and loss of interest), and anxiety (intense, excessive, and persistent worry and fear about everyday
situations). Record review of Resident #5's care plan revised on 06/10/25 reflected the resident had an ADL
self-care performance deficit related to diagnoses of schizophrenia, depression, malnutrition, anxiety,
tremor, right hand contracture, and neuropathy. Interventions included 1 staff participation requirement.
Observation and interview on 08/12/25 at 11:43 AM with Resident #73 revealed a line of approximately 40
ants on the floor beside Resident #73's bed. Resident #73 stated she had not been bitten by the ants.
Resident #73 also said that she had not seen ants before in her room. There were crumbs on the resident's
floor, and it appeared the ants were going towards the crumbs. There were no ants observed on the
resident or her bed. Observation and interview on 08/12/25 at 11:48 AM with Resident #5 revealed she saw
ants about a week ago beside her roommate's bed. Resident #5 stated she had not seen ants in the past
week. Interview on 08/12/25 at 12:08 PM with the Maintenance Director revealed the pest control company
visited the facility every other Thursday. He stated he did not think the resident's room had been treated for
ants recently because there had not been a request for that room to be treated for ants. He stated if just a
few ants were seen, he would log it into the pest control book. He then said that if a trail of ants were seen,
he would call the pest control company and have them come out immediately to the facility to treat the area.
He also stated the facility policy stated that if ants are found in a resident's room, the residents would be
moved to another room, showered, assessed by a nurse, and treated if necessary. He revealed he would
examine where the ants were coming from as well and report this to the Regional Director and the
Administrator. The Maintenance Director stated the pest control company had been contacted about the
ants and
Residents Affected - Few
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
675977
If continuation sheet
Page 6 of 7
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
675977
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
08/14/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Village Creek Nursing & Rehabilitation
3825 Village Creek Rd
Fort Worth, TX 76119
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0925
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
FORM CMS-2567 (02/99)
Previous Versions Obsolete
would be coming to the facility that afternoon to prevent any risk to the residents such as ant bites.
Interview on 08/12/25 at 12:24 PM with the Administrator revealed Resident #73 had been taken by the
staff to be showered. She stated the resident would be assessed for injuries as well. She also revealed she
had notified the pest control company, and they would be arriving later in the afternoon. The Administrator
said she moved both residents to another room to prevent any injuries from occurring to the residents.
Interview on 08/14/25 at 1:49 PM with CNA B revealed she had not observed ants in Resident #73's room.
She stated if she saw ants or other pests, she would report it to her nurse and the maintenance director by
using the computer system that the facility utilized for reporting maintenance issues. She also revealed she
would follow-up with her ADON if results were not seen timely, so they could check the resident for bites for
the safety of the resident. She stated pests like ants could bite residents if not treated and eliminated. She
stated she saw a pest control person treating the facility regularly. Interview on 08/14/25 at 1:59 PM with
MA C revealed he had gone into Resident #73's room many times to give the resident her medications. He
stated he had not seen any ants in her room any of those times. He said he would notify the nurse, DON,
and Administrator, if he saw ants, so they could call the pest control company. He stated ants presented an
infection control risk to residents by getting into their food and residents then eating that food. Interview on
08/14/25 at 2:08 PM with CNA D revealed he had not seen ants in Resident #73's room while providing
care to Resident #73. He stated if he saw ants in a resident's room, he would notify his charge nurse and
the Administrator. He stated the resident would be at risk of ant bites if ants were allowed to stay in the
resident's room. He said if ants were found in a resident's room, the resident would be showered, changed,
and an assessment completed to evaluate for injuries. CNA D recalled the facility was treated regularly for
ants. He stated if there was not an immediate response to his initial claim that ants were in a resident's
room, he would notify the Administrator. Record review of the facility's current, undated Pest Control policy
reflected: The facility maintains an ongoing pest control program to ensure the building and grounds are
kept free of insects, rodents, and other pests.
Event ID:
Facility ID:
675977
If continuation sheet
Page 7 of 7